The effect of temazepam on melatonin secretion and light sensitivity

N H Allen1, P J Smythe, N Martin

  • 1Department of Psychiatry, Royal South Hants Hospital, Southampton, Hants SO9 4PE.

Insights

Temazepam, a short-acting hypnotic, does not affect melatonin secretion timing or light sensitivity. This finding indicates temazepam is suitable for studies measuring circadian rhythm and light responses.

Area of Science:

  • Chronobiology
  • Pharmacology
  • Neuroscience

Background:

  • Melatonin secretion is a key marker for circadian rhythms.
  • Light exposure significantly influences melatonin production and timing.
  • Benzodiazepines are commonly used hypnotics, but their effects on circadian markers are not fully understood.

Purpose of the Study:

  • To investigate the impact of temazepam on melatonin secretion and light sensitivity.
  • To determine if temazepam confounds measurements of circadian phase and photic melatonin suppression.

Main Methods:

  • Seven healthy males received 20 mg of temazepam daily for seven days.
  • Melatonin onset, peak, total secretion, and light sensitivity were measured before and after treatment.
  • Full-spectrum light was used to assess melatonin suppression.

Main Results:

  • Temazepam treatment did not alter the dim light melatonin onset (DLMO).
  • No significant changes were observed in total melatonin secretion.
  • The sensitivity of melatonin secretion to light suppression remained unaffected.

Conclusions:

  • Short-term temazepam use does not interfere with circadian melatonin phase.
  • Temazepam does not confound the assessment of light sensitivity in melatonin suppression tests.
  • These findings support the use of temazepam in research involving circadian rhythm and light sensitivity studies.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
The Pineal Gland01:02

The Pineal Gland

The pineal gland, a diminutive endocrine structure named for its pinecone-shaped appearance, is situated atop the third ventricle within the diencephalon region of the forebrain. This gland, composed of secretory cells known as pinealocytes arranged in compact cords and clusters around dense particles of calcium salts, plays a pivotal role in hormonal regulation.
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...